NCT04995848

Telepalliation - Digital Platform for Patients in Palliation and Their Relatives

Status unknown NA Last updated 19 July 2023

What this trial tests

NA trial testing Telepalliation in Cancer in 182 participants. Status unknown.

Timeline

26 May 2021

Primary endpoint
1 August 2024

1 August 2024

Quick facts

Lead sponsor	Aalborg University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	182
Start date	26 May 2021
Primary completion	1 August 2024
Estimated completion	1 August 2024
Sites	1 location across Denmark

Drugs / interventions tested

• Telepalliation

Conditions studied

• Cancer — all drugs for Cancer →
• Heart Failure — all drugs for Heart Failure →
• Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
• Neurological Diseases — all drugs for Neurological Diseases →

Sponsor

Aalborg University

Who can join

18 and older, any sex, with Cancer or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project has focus on patients in palliation testing a digital platform TelePal.dk.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Telepalliation creates a sense of security: A qualitative study of patients with cancer receiving palliative care.
   Sigaard JVA, Joensen EDR, Birgisdóttir UR, Spindler H, et al · · 2026 · cited 2× · PMID 41055129 · DOI 10.1177/02692163251364145
2. A Digital Platform (Telepalliation) for Patients in Palliative Care and Their Relatives: Protocol for a Multimethod Randomized Controlled Trial.
   Sigaard JVA, Henneberg NC, Schacksen CS, Kronborg SH, et al · · 2024 · cited 2× · PMID 38564264 · DOI 10.2196/49946